AG0065SG

72496-41-4 | (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

Chemical structure of (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione, CAS 72496-41-4
AG0065SG
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 72496-41-4
Catalog Number AG0065SG(AGN-PC-0068I6)
Chemical Name (8S,10S)-10-[[3-Amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
IUPAC Name (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2S)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
InChI InChI=1S/C32H37NO12/c1-14-31(45-21-8-3-4-9-42-21)17(33)10-22(43-14)44-19-12-32(40,20(35)13-34)11-16-24(19)30(39)26-25(28(16)37)27(36)15-6-5-7-18(41-2)23(15)29(26)38/h5-7,14,17,19,21-22,31,34,37,39-40H,3-4,8-13,33H2,1-2H3/t14-,17-,19-,21-,22-,31+,32-/m0/s1
InChI Key KMSKQZKKOZQFFG-HSUXVGOQSA-N
MDL Number MFCD00869742
Molecular Formula C32H37NO12
Molecular Weight 627.6357
SMILES N[C@H]1C[C@@H](O[C@H]([C@H]1O[C@H]1OCCCC1)C)O[C@H]1C[C@@](CC=2C(=C3C(C=4C=CC=C(C4C(C3=C(C12)O)=O)OC)=O)O)(C(CO)=O)O
Synonyms
4'-O-tetrahydropyranyladriamycin, 4'-O-tetrahydropyranyldoxorubicin, 4'-O-tetrapyranyldoxorubicin, pirarubicin, pirarubicin hydrochloride, Théprubicine, thepirubicin, Theprubicin, therarubicin, THP-ADM, THP-adriamycin, THP-DOX, THP-doxorubicin, pirarubicin, 72496-41-4, Theprubicin, MFCD00869742, THP-doxorubicin, C32H37NO12, NCGC00167982-01, AC1LCS5T, Pirarubicin (JP17/INN), CHEMBL1398373, SCHEMBL15472856, CHEBI:32011, AOB5649, EX-A494, KMSKQZKKOZQFFG-HSUXVGOQSA-N, ZINC3913909, AKOS015895621, NCGC00167982-02, BC225325, K234, D01885, 15207-EP2272827A1, 15207-EP2275420A1, 15207-EP2295055A2, 15207-EP2295416A2, 15207-EP2295426A1, 15207-EP2295427A1, 15207-EP2298748A2, 15207-EP2298764A1, 15207-EP2298765A1, 15207-EP2298768A1, 15207-EP2298778A1, 15207-EP2305642A2, 15207-EP2311453A1, 15207-EP2311808A1, 15207-EP2311829A1, 15207-EP2316832A1, 15207-EP2316833A1, 496P414, Pirarubicin, Antibiotic for Culture Media Use Only, Q-201589, (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2S)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione, (8S)-10-((2R,4S,5S,6S)-4-amino-6-methyl-5-((S)-tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-6-methyl-5-(((S)-tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione, Pirarubicinum, Pirarubicina, Pirarubicine, Theprubicin-HCl, THP-adriamycin, Therarubicin (TN), Pirarubicine [French], Pirarubicinum [Latin], Pirarubicina [Spanish], THP-ADM, Pirarubicin [INN:JAN], UNII-D58G680W0G, UNII-E7V83174BE, 4'-O-Tetrahydropyranyladriamycin, 4'-O-Tetrahydropyranyldoxorubicin, 1609RB, CID636397, C32-H37-N-O12, ACN-036871, (2" R)-4'-O-Tetrahydropyranyladriamycin, (2''R)-4'-O-Tetrahydropyranyladriamycin, ThP, (8S,10S)-10-((2R,4S,5S,6S)-4-amino-tetrahydro-6-methyl-5-(tetrahydro-2H-pyran-2-yloxy)-2H-pyran-2-yloxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione, 5,12-Naphthacenedione, 10-[[3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-.alpha.-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited